ALPS Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-75,374
| Closed | -$1.78M | – | 1086 |
|
|
2023
Q4 | $1.78M | Buy |
75,374
+2,913
| +4% | +$68.8K | 0.01% | 352 |
|
|
2023
Q3 | $1.08M | Buy |
72,461
+783
| +1% | +$11.7K | 0.01% | 422 |
|
|
2023
Q2 | $785K | Buy |
71,678
+9,298
| +15% | +$102K | 0.01% | 537 |
|
|
2023
Q1 | $544K | Buy |
62,380
+4,874
| +8% | +$42.5K | ﹤0.01% | 582 |
|
|
2022
Q4 | $361K | Buy |
+57,506
| New | +$361K | ﹤0.01% | 724 |
|
|
2018
Q4 | – | Sell |
-104,500
| Closed | -$1.16M | – | 960 |
|
|
2018
Q3 | $1.16M | Buy |
104,500
+19,213
| +23% | +$213K | 0.01% | 348 |
|
|
2018
Q2 | $1.15M | Buy |
+85,287
| New | +$1.15M | 0.01% | 307 |
|